← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 26, 2015Last known activity
Nov 30, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT07304882Lead sponsorPhase 3Nov 30, 2023
- NCT07304882Sponsor investigatorPhase 3Nov 30, 2023
- NCT03348241Overall official - principal investigatorPhase 2Oct 26, 2015
- NCT03348241Reponsible party - principal investigatorPhase 2Oct 26, 2015
- NCT03348241Lead sponsorPhase 2Oct 26, 2015
Details
- Last known activity
- Nov 30, 2023